{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:16:25Z","timestamp":1790702185062,"version":"4.1.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,4,8]],"date-time":"2022-04-08T00:00:00Z","timestamp":1649376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,4,8]],"date-time":"2022-04-08T00:00:00Z","timestamp":1649376000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs Aging"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1007\/s40266-022-00930-5","type":"journal-article","created":{"date-parts":[[2022,4,8]],"date-time":"2022-04-08T02:10:20Z","timestamp":1649383820000},"page":"315-321","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Seborrheic Dermatitis in Older Adults: Pathogenesis and Treatment Options"],"prefix":"10.1007","volume":"39","author":[{"given":"Josiah","family":"Sowell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1753-4725","authenticated-orcid":false,"given":"Sandra M.","family":"Pena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boni E.","family":"Elewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,8]]},"reference":[{"issue":"1","key":"930_CR1","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/j.1468-3083.2004.00693.x","volume":"18","author":"AK Gupta","year":"2004","unstructured":"Gupta AK, Bluhm R. Seborrheic dermatitis. J Eur Acad Dermatol Venereol. 2004;18(1):13\u201326. https:\/\/doi.org\/10.1111\/j.1468-3083.2004.00693.x(quiz 19\u201320).","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"930_CR2","first-page":"125","volume":"74","author":"RA Schwartz","year":"2006","unstructured":"Schwartz RA, Janusz CA, Janniger CK. Seborrheic dermatitis: an overview. Am Fam Physician. 2006;74(1):125\u201330.","journal-title":"Am Fam Physician"},{"issue":"3","key":"930_CR3","first-page":"185","volume":"91","author":"GW Clark","year":"2015","unstructured":"Clark GW, Pope SM, Jaboori KA. Diagnosis and treatment of seborrheic dermatitis. Am Fam Physician. 2015;91(3):185\u201390.","journal-title":"Am Fam Physician"},{"issue":"4","key":"930_CR4","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.clindermatol.2013.01.001","volume":"31","author":"C Dessinioti","year":"2013","unstructured":"Dessinioti C, Katsambas A. Seborrheic dermatitis: etiology, risk factors, and treatments: facts and controversies. Clin Dermatol. 2013;31(4):343\u201351. https:\/\/doi.org\/10.1016\/j.clindermatol.2013.01.001.","journal-title":"Clin Dermatol"},{"issue":"6","key":"930_CR5","first-page":"333","volume":"83","author":"BE Elewski","year":"2009","unstructured":"Elewski BE. Safe and effective treatment of seborrheic dermatitis. Cutis. 2009;83(6):333\u20138.","journal-title":"Cutis"},{"issue":"4","key":"930_CR6","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1111\/j.1439-0507.2008.01624.x","volume":"52","author":"JC Szepietowski","year":"2009","unstructured":"Szepietowski JC, Reich A, Weso\u0142owska-Szepietowska E, Baran E, National Quality of Life in Dermatology Group. Quality of life in patients suffering from seborrheic dermatitis: influence of age, gender and education level. Mycoses. 2009;52(4):357\u201363. https:\/\/doi.org\/10.1111\/j.1439-0507.2008.01624.x.","journal-title":"Mycoses"},{"issue":"2","key":"930_CR7","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1159\/000076478","volume":"208","author":"AK Gupta","year":"2004","unstructured":"Gupta AK, Madzia SE, Batra R. Etiology and management of seborrheic dermatitis. Dermatology. 2004;208(2):89\u201393. https:\/\/doi.org\/10.1159\/000076478.","journal-title":"Dermatology"},{"issue":"5","key":"930_CR8","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1111\/exd.14091","volume":"29","author":"JA Adalsteinsson","year":"2020","unstructured":"Adalsteinsson JA, Kaushik S, Muzumdar S, Guttman-Yassky E, Ungar J. An update on the microbiology, immunology and genetics of seborrheic dermatitis. Exp Dermatol. 2020;29(5):481\u20139. https:\/\/doi.org\/10.1111\/exd.14091.","journal-title":"Exp Dermatol"},{"issue":"1","key":"930_CR9","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1111\/j.1365-4632.2011.04964.x","volume":"51","author":"JA Breunig","year":"2012","unstructured":"Breunig JA, de Almeida Jr. HL, Duquia RP, Souza PR, Staub HL. Scalp seborrheic dermatitis: prevalence and associated factors in male adolescents. Int J Dermatol. 2012;51(1):46\u20139. https:\/\/doi.org\/10.1111\/j.1365-4632.2011.04964.x.","journal-title":"Int J Dermatol"},{"issue":"6 Suppl.","key":"930_CR10","doi-asserted-by":"publisher","first-page":"S39","DOI":"10.1016\/j.clindermatol.2009.09.001","volume":"27","author":"JQ Del Rosso","year":"2009","unstructured":"Del Rosso JQ. Perspectives on seborrheic dermatitis: looking back to move ahead. Clin Dermatol. 2009;27(6 Suppl.):S39\u201340. https:\/\/doi.org\/10.1016\/j.clindermatol.2009.09.001.","journal-title":"Clin Dermatol"},{"issue":"6","key":"930_CR11","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1001\/archderm.1983.01650300027010","volume":"119","author":"RL Binder","year":"1983","unstructured":"Binder RL, Jonelis FJ. Seborrheic dermatitis in neuroleptic-induced parkinsonism. Arch Dermatol. 1983;119(6):473\u20135.","journal-title":"Arch Dermatol"},{"issue":"3","key":"930_CR12","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1111\/j.1365-2133.1973.tb07545.x","volume":"88","author":"JL Burton","year":"1973","unstructured":"Burton JL, Cartlidge M, Cartlidge NE, Shuster S. Sebum excretion in Parkinsonism. Br J Dermatol. 1973;88(3):263\u20136. https:\/\/doi.org\/10.1111\/j.1365-2133.1973.tb07545.x.","journal-title":"Br J Dermatol"},{"issue":"4","key":"930_CR13","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1080\/00015550410025877","volume":"84","author":"M Mastrolonardo","year":"2004","unstructured":"Mastrolonardo M, Diaferio A, Vendemiale G, Lopalco P. Seborrhoeic dermatitis in the elderly: inferences on the possible role of disability and loss of self-sufficiency. Acta Derm Venereol. 2004;84(4):285\u20137. https:\/\/doi.org\/10.1080\/00015550410025877.","journal-title":"Acta Derm Venereol"},{"issue":"12","key":"930_CR14","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1001\/archderm.1987.01660360066014","volume":"123","author":"S Beauregard","year":"1987","unstructured":"Beauregard S, Gilchrest BA. A survey of skin problems and skin care regimens in the elderly. Arch Dermatol. 1987;123(12):1638\u201343.","journal-title":"Arch Dermatol"},{"issue":"3","key":"930_CR15","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1111\/j.1346-8138.1998.tb02371.x","volume":"25","author":"Y Thaipisuttikul","year":"1998","unstructured":"Thaipisuttikul Y. Pruritic skin diseases in the elderly. J Dermatol. 1998;25(3):153\u20137. https:\/\/doi.org\/10.1111\/j.1346-8138.1998.tb02371.x.","journal-title":"J Dermatol"},{"issue":"4","key":"930_CR16","doi-asserted-by":"crossref","first-page":"352","DOI":"10.2340\/0001555560352353","volume":"60","author":"K Weismann","year":"1980","unstructured":"Weismann K, Krakauer R, Wanscher B. Prevalence of skin diseases in old age. Acta Derm Venereol. 1980;60(4):352\u20133.","journal-title":"Acta Derm Venereol"},{"issue":"3","key":"930_CR17","first-page":"359","volume":"18","author":"JP Tindall","year":"1976","unstructured":"Tindall JP. Skin changes and lesions in our senior citizens: incidences. Cutis. 1976;18(3):359\u201362.","journal-title":"Cutis"},{"issue":"1","key":"930_CR18","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1111\/bjd.15908","volume":"178","author":"MGH Sanders","year":"2018","unstructured":"Sanders MGH, Pardo LM, Franco OH, Ginger RS, Nijsten T. Prevalence and determinants of seborrhoeic dermatitis in a middle-aged and elderly population: the Rotterdam Study. Br J Dermatol. 2018;178(1):148\u201353. https:\/\/doi.org\/10.1111\/bjd.15908.","journal-title":"Br J Dermatol"},{"issue":"1","key":"930_CR19","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/1523-1747.ep12532758","volume":"73","author":"AM Kligman","year":"1979","unstructured":"Kligman AM. Perspectives and problems in cutaneous gerontology. J Investig Dermatol. 1979;73(1):39\u201346. https:\/\/doi.org\/10.1111\/1523-1747.ep12532758.","journal-title":"J Investig Dermatol"},{"issue":"2","key":"930_CR20","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/j.1532-5415.1991.tb01612.x","volume":"39","author":"LP Fried","year":"1991","unstructured":"Fried LP, Storer DJ, King DE, Lodder F. Diagnosis of illness presentation in the elderly. J Am Geriatr Soc. 1991;39(2):117\u201323. https:\/\/doi.org\/10.1111\/j.1532-5415.1991.tb01612.x.","journal-title":"J Am Geriatr Soc"},{"key":"930_CR21","doi-asserted-by":"publisher","unstructured":"Osborn DP, Fletcher AE, Smeeth L, Stirling S, Nunes M, Breeze E, et al. Geriatric Depression Scale Scores in a representative sample of 14 545 people aged 75 and over in the United Kingdom: results from the MRC Trial of Assessment and Management of Older People in the Community. Int J Geriatr Psychiatry. 2002;17(4):375\u201382. https:\/\/doi.org\/10.1002\/gps.613 (Erratum in: Int J Geriatr Psychiatry 2002;17(6):592. Siu-Woon Edmond [corrected to Siu-Woon Ng Edmond]).","DOI":"10.1002\/gps.613"},{"key":"930_CR22","unstructured":"Johnson BA, Nunley JR. Treatment of seborrheic dermatitis. Am Fam Physician. 2000;61(9):2703\u201310, 2713\u20134."},{"issue":"10","key":"930_CR23","doi-asserted-by":"publisher","first-page":"2464","DOI":"10.1111\/jocd.13669","volume":"19","author":"S Veraldi","year":"2020","unstructured":"Veraldi S, Angileri L, Barbareschi M. Seborrheic dermatitis and anti-COVID-19 masks. J Cosmet Dermatol. 2020;19(10):2464\u20135. https:\/\/doi.org\/10.1111\/jocd.13669.","journal-title":"J Cosmet Dermatol"},{"key":"930_CR24","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.14623","author":"HC Wang","year":"2021","unstructured":"Wang HC, Wang CS, Hsieh SC, Hung YT, Chen HH. Evaluation of a new-formula shampoo containing 6% glycyrrhetinic acid complex for scalp seborrheic dermatitis: a pilot study. J Cosmet Dermatol. 2021. https:\/\/doi.org\/10.1111\/jocd.14623.","journal-title":"J Cosmet Dermatol"},{"issue":"Suppl. 2","key":"930_CR25","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/j.1365-4632.2007.03349.x","volume":"46","author":"EN Nnoruka","year":"2007","unstructured":"Nnoruka EN, Chukwuka JC, Anisuiba B. Correlation of mucocutaneous manifestations of HIV\/AIDS infection with CD4 counts and disease progression. Int J Dermatol. 2007;46(Suppl. 2):14\u20138. https:\/\/doi.org\/10.1111\/j.1365-4632.2007.03349.x.","journal-title":"Int J Dermatol"},{"issue":"5","key":"930_CR26","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1111\/j.1468-3083.2009.03470.x","volume":"24","author":"A Lally","year":"2010","unstructured":"Lally A, Casabonne D, Newton R, Wojnarowska F. Seborrheic dermatitis among Oxford renal transplant recipients. J Eur Acad Dermatol Venereol. 2010;24(5):561\u20134. https:\/\/doi.org\/10.1111\/j.1468-3083.2009.03470.x.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5","key":"930_CR27","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1080\/000155598443051","volume":"78","author":"B Cribier","year":"1998","unstructured":"Cribier B, Samain F, Vetter D, Heid E, Grosshans E. Systematic cutaneous examination in hepatitis C virus infected patients. Acta Derm Venereol. 1998;78(5):355\u20137. https:\/\/doi.org\/10.1080\/000155598443051.","journal-title":"Acta Derm Venereol"},{"issue":"1","key":"930_CR28","first-page":"48","volume":"68","author":"DC Clift","year":"1988","unstructured":"Clift DC, Dodd HJ, Kirby JD, Midgley G, Noble WC. Seborrheic dermatitis and malignancy: an investigation of the skin flora. Acta Derm Venereol. 1988;68(1):48\u201352.","journal-title":"Acta Derm Venereol"},{"issue":"3","key":"930_CR29","first-page":"217","volume":"48","author":"CT Marino","year":"1991","unstructured":"Marino CT, McDonald E, Romano JF. Seborrheic dermatitis in acquired immunodeficiency syndrome. Cutis. 1991;48(3):217\u20138.","journal-title":"Cutis"},{"issue":"3","key":"930_CR30","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1046\/j.1365-2133.2001.04082.x","volume":"144","author":"J Faergemann","year":"2001","unstructured":"Faergemann J, Bergbrant IM, Dohs\u00e9 M, Scott A, Westgate G. Seborrhoeic dermatitis and Pityrosporum (Malassezia) folliculitis: characterization of inflammatory cells and mediators in the skin by immunohistochemistry. Br J Dermatol. 2001;144(3):549\u201356. https:\/\/doi.org\/10.1046\/j.1365-2133.2001.04082.x.","journal-title":"Br J Dermatol"},{"key":"930_CR31","doi-asserted-by":"publisher","first-page":"758","DOI":"10.3389\/fneur.2019.00758","volume":"10","author":"M Laurence","year":"2019","unstructured":"Laurence M, Benito-Le\u00f3n J, Calon F. Malassezia and Parkinson\u2019s disease. Front Neurol. 2019;10:758. https:\/\/doi.org\/10.3389\/fneur.2019.00758.","journal-title":"Front Neurol"},{"issue":"3","key":"930_CR32","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1111\/j.1087-0024.2005.10103.x","volume":"10","author":"BE Elewski","year":"2005","unstructured":"Elewski BE. Clinical diagnosis of common scalp disorders. J Investig Dermatol Symp Proc. 2005;10(3):190\u20133. https:\/\/doi.org\/10.1111\/j.1087-0024.2005.10103.x.","journal-title":"J Investig Dermatol Symp Proc"},{"issue":"1","key":"930_CR33","first-page":"24","volume":"18","author":"M Elgash","year":"2019","unstructured":"Elgash M, Dlova N, Ogunleye T, Taylor SC. Seborrheic dermatitis in skin of color: clinical considerations. J Drugs Dermatol. 2019;18(1):24\u20137.","journal-title":"J Drugs Dermatol"},{"key":"930_CR34","doi-asserted-by":"publisher","DOI":"10.13188\/2373-1044.1000019","author":"LJ Borda","year":"2015","unstructured":"Borda LJ, Wikramanayake TC. Seborrheic dermatitis and dandruff: a comprehensive review. J Clin Investig Dermatol. 2015. https:\/\/doi.org\/10.13188\/2373-1044.1000019.","journal-title":"J Clin Investig Dermatol"},{"issue":"2","key":"930_CR35","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1080\/09546634.2018.1473554","volume":"30","author":"LJ Borda","year":"2019","unstructured":"Borda LJ, Perper M, Keri JE. Treatment of seborrheic dermatitis: a comprehensive review. J Dermatolog Treat. 2019;30(2):158\u201369. https:\/\/doi.org\/10.1080\/09546634.2018.1473554.","journal-title":"J Dermatolog Treat"},{"issue":"3","key":"930_CR36","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s40266-015-0246-0","volume":"32","author":"R Valdes-Rodriguez","year":"2015","unstructured":"Valdes-Rodriguez R, Stull C, Yosipovitch G. Chronic pruritus in the elderly: pathophysiology, diagnosis and management. Drugs Aging. 2015;32(3):201\u201315. https:\/\/doi.org\/10.1007\/s40266-015-0246-0.","journal-title":"Drugs Aging"},{"issue":"4","key":"930_CR37","doi-asserted-by":"publisher","first-page":"521.e1\u201310","DOI":"10.1016\/j.jaad.2012.10.063","volume":"68","author":"JO Endo","year":"2013","unstructured":"Endo JO, Wong JW, Norman RA. Geriatric dermatology: part I. Geriatric pharmacology for the dermatologist. J Am Acad Dermatol. 2013;68(4):521.e1\u201310 (quiz 531\u20132).","journal-title":"J Am Acad Dermatol"},{"key":"930_CR38","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1111\/j.1365-2133.2007.07919.x","volume":"156","author":"H van Os-Medendorp","year":"2007","unstructured":"van Os-Medendorp H, Ros WJ, Eland-de Kok PC, Kennedy C, Thio BH, et al. Effectiveness of the nursing programme \u2018Coping with Itch\u2019: a randomized controlled study in adults with chronic pruritic skin disease. Br J Dermatol. 2007;156:1235\u201344.","journal-title":"Br J Dermatol"},{"issue":"3\u20134","key":"930_CR39","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3121\/cmr.2017.1363","volume":"15","author":"S Purnamawati","year":"2017","unstructured":"Purnamawati S, Indrastuti N, Danarti R, Saefudin T. The role of moisturizers in addressing various kinds of dermatitis: a review. Clin Med Res. 2017;15(3\u20134):75\u201387. https:\/\/doi.org\/10.3121\/cmr.2017.1363.","journal-title":"Clin Med Res"},{"issue":"3","key":"930_CR40","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s13555-019-00319-0","volume":"9","author":"J Piquero-Casals","year":"2019","unstructured":"Piquero-Casals J, Hexsel D, Mir-Bonaf\u00e9 JF, Rozas-Mu\u00f1oz E. Topical non-pharmacological treatment for facial seborrheic dermatitis. Dermatol Ther (Heidelb). 2019;9(3):469\u201377. https:\/\/doi.org\/10.1007\/s13555-019-00319-0.","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"12","key":"930_CR41","doi-asserted-by":"publisher","first-page":"881","DOI":"10.2147\/CCID.S231313","volume":"16","author":"E Campione","year":"2019","unstructured":"Campione E, Mazzilli S, Lanna C, Cosio T, Palumbo V, Cesaroni G, et al. The effectiveness of a new topical formulation containing GSH-C4 and hyaluronic acid in seborrheic dermatitis: preliminary results of an exploratory pilot study. Clin Cosmet Investig Dermatol. 2019;16(12):881\u20135. https:\/\/doi.org\/10.2147\/CCID.S231313.","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"5","key":"930_CR42","first-page":"329","volume":"95","author":"C Baumert","year":"2017","unstructured":"Baumert C, Melo M, Vincent EC. Topical medications for seborrheic dermatitis. Am Fam Physician. 2017;95(5):329.","journal-title":"Am Fam Physician"},{"issue":"4","key":"930_CR43","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1159\/000247566","volume":"184","author":"JP Ortonne","year":"1992","unstructured":"Ortonne JP, Lacour JP, Vitetta A, Le Fichoux Y. Comparative study of ketoconazole 2% foaming gel and betamethasone dipropionate 0.05% lotion in the treatment of seborrhoeic dermatitis in adults. Dermatology. 1992;184(4):275\u201380. https:\/\/doi.org\/10.1159\/000247566.","journal-title":"Dermatology"},{"issue":"6","key":"930_CR44","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1016\/0190-9622(93)70282-x","volume":"29","author":"FW Danby","year":"1993","unstructured":"Danby FW, Maddin WS, Margesson LJ, Rosenthal D. A randomized, double-blind, placebo-controlled trial of ketoconazole 2% shampoo versus selenium sulfide 2.5% shampoo in the treatment of moderate to severe dandruff. J Am Acad Dermatol. 1993;29(6):1008\u201312. https:\/\/doi.org\/10.1016\/0190-9622(93)70282-x.","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"930_CR45","doi-asserted-by":"publisher","first-page":"226","DOI":"10.3109\/09546634.2013.782092","volume":"25","author":"SA Buechner","year":"2014","unstructured":"Buechner SA. Multicenter, double-blind, parallel group study investigating the non-inferiority of efficacy and safety of a 2% miconazole nitrate shampoo in comparison with a 2% ketoconazole shampoo in the treatment of seborrhoeic dermatitis of the scalp. J Dermatolog Treat. 2014;25(3):226\u201331. https:\/\/doi.org\/10.3109\/09546634.2013.782092.","journal-title":"J Dermatolog Treat"},{"issue":"1","key":"930_CR46","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1080\/09546630802286993","volume":"20","author":"E Koc","year":"2009","unstructured":"Koc E, Arca E, Kose O, Akar A. An open, randomized, prospective, comparative study of topical pimecrolimus 1% cream and topical ketoconazole 2% cream in the treatment of seborrheic dermatitis. J Dermatolog Treat. 2009;20(1):4\u20139. https:\/\/doi.org\/10.1080\/09546630802286993.","journal-title":"J Dermatolog Treat"},{"issue":"5","key":"930_CR47","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1111\/j.1365-2133.2004.06208.x","volume":"151","author":"D Rigopoulos","year":"2004","unstructured":"Rigopoulos D, Ioannides D, Kalogeromitros D, Gregoriou S, Katsambas A. Pimecrolimus cream 1% vs. betamethasone 17-valerate 0.1% cream in the treatment of seborrhoeic dermatitis: a randomized open-label clinical trial. Br J Dermatol. 2004;151(5):1071\u20135. https:\/\/doi.org\/10.1111\/j.1365-2133.2004.06208.x.","journal-title":"Br J Dermatol"},{"issue":"2","key":"930_CR48","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.ijwd.2016.11.008","volume":"3","author":"K Balighi","year":"2016","unstructured":"Balighi K, Ghodsi SZ, Daneshpazhooh M, Ghale-Baghi S, Nasimi M, Azizpour A. Hydrocortisone 1% cream and sertaconazole 2% cream to treat facial seborrheic dermatitis: a double-blind, randomized clinical trial. Int J Womens Dermatol. 2016;3(2):107\u201310. https:\/\/doi.org\/10.1016\/j.ijwd.2016.11.008.","journal-title":"Int J Womens Dermatol."},{"issue":"6","key":"930_CR49","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1046\/j.1365-2133.2003.05383.x","volume":"148","author":"TJ Braza","year":"2003","unstructured":"Braza TJ, DiCarlo JB, Soon SL, McCall CO. Tacrolimus 0.1% ointment for seborrhoeic dermatitis: an open-label pilot study. Br J Dermatol. 2003;148(6):1242\u20134. https:\/\/doi.org\/10.1046\/j.1365-2133.2003.05383.x.","journal-title":"Br J Dermatol"},{"issue":"2","key":"930_CR50","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.jaad.2006.11.007","volume":"57","author":"EM Warshaw","year":"2007","unstructured":"Warshaw EM, Wohlhuter RJ, Liu A, Zeller SA, Wenner RA, Bowers S, et al. Results of a randomized, double-blind, vehicle-controlled efficacy trial of pimecrolimus cream 1% for the treatment of moderate to severe facial seborrheic dermatitis. J Am Acad Dermatol. 2007;57(2):257\u201364. https:\/\/doi.org\/10.1016\/j.jaad.2006.11.007.","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"930_CR51","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1177\/1203475415574970","volume":"19","author":"AK Gupta","year":"2015","unstructured":"Gupta AK, Lyons DC. The rise and fall of oral ketoconazole. J Cutan Med Surg. 2015;19(4):352\u20137. https:\/\/doi.org\/10.1177\/1203475415574970.","journal-title":"J Cutan Med Surg"},{"issue":"5","key":"930_CR52","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s40257-015-0133-9","volume":"16","author":"SZ Ghodsi","year":"2015","unstructured":"Ghodsi SZ, Abbas Z, Abedeni R. Efficacy of oral itraconazole in the treatment and relapse prevention of moderate to severe seborrheic dermatitis: a randomized, placebo-controlled trial. Am J Clin Dermatol. 2015;16(5):431\u20137. https:\/\/doi.org\/10.1007\/s40257-015-0133-9.","journal-title":"Am J Clin Dermatol"},{"issue":"4","key":"930_CR53","doi-asserted-by":"publisher","first-page":"235","DOI":"10.2165\/00128071-200708040-00005","volume":"8","author":"A C\u00f6mert","year":"2007","unstructured":"C\u00f6mert A, Bekiroglu N, G\u00fcrb\u00fcz O, Ergun T. Efficacy of oral fluconazole in the treatment of seborrheic dermatitis: a placebo-controlled study. Am J Clin Dermatol. 2007;8(4):235\u20138. https:\/\/doi.org\/10.2165\/00128071-200708040-00005.","journal-title":"Am J Clin Dermatol"},{"issue":"10","key":"930_CR54","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1038\/sj.jid.5700418","volume":"126","author":"CC Zouboulis","year":"2006","unstructured":"Zouboulis CC. Isotretinoin revisited: pluripotent effects on human sebaceous gland cells. J Investig Dermatol. 2006;126(10):2154\u20136. https:\/\/doi.org\/10.1038\/sj.jid.5700418.","journal-title":"J Investig Dermatol"},{"issue":"2","key":"930_CR55","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1177\/1203475416676806","volume":"21","author":"M Rademaker","year":"2017","unstructured":"Rademaker M. Low-dose isotretinoin for seborrhoeic dermatitis. J Cutan Med Surg. 2017;21(2):170\u20131. https:\/\/doi.org\/10.1177\/1203475416676806.","journal-title":"J Cutan Med Surg"},{"issue":"3","key":"930_CR56","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1111\/dth.12213","volume":"28","author":"HM Ahmad","year":"2015","unstructured":"Ahmad HM. Analysis of clinical efficacy, side effects, and laboratory changes among patients with acne vulgaris receiving single versus twice daily dose of oral isotretinoin. Dermatol Ther. 2015;28(3):151\u20137. https:\/\/doi.org\/10.1111\/dth.12213.","journal-title":"Dermatol Ther"},{"issue":"12","key":"930_CR57","doi-asserted-by":"publisher","first-page":"e809","DOI":"10.1111\/jdv.16673","volume":"34","author":"SM Pe\u00f1a","year":"2020","unstructured":"Pe\u00f1a SM, Oak ASW, Smith AM, Mayo TT, Elewski BE. Topical crisaborole is an efficacious steroid-sparing agent for treating mild-to-moderate seborrhoeic dermatitis. J Eur Acad Dermatol Venereol. 2020;34(12):e809\u201312. https:\/\/doi.org\/10.1111\/jdv.16673.","journal-title":"J Eur Acad Dermatol Venereol"}],"container-title":["Drugs & Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-022-00930-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40266-022-00930-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-022-00930-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T15:05:27Z","timestamp":1700406327000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40266-022-00930-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,8]]},"references-count":57,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["930"],"URL":"https:\/\/doi.org\/10.1007\/s40266-022-00930-5","relation":{},"ISSN":["1170-229X","1179-1969"],"issn-type":[{"value":"1170-229X","type":"print"},{"value":"1179-1969","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,8]]},"assertion":[{"value":"23 February 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article has no funding source.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"SMP and JS have no conflicts of interest to declare. BEE has received consulting fees or honorarium from Arcutis, Boehringer Ingelheim, Bristol Myers Squibb, Amgen (previously Celgene), LEO, Eli Lilly, Menlo, Novartis, Pfizer, Sun Pharma, UCB, Valeant (Ortho Dermatologics), and Verrica; and has received research funding to her university from AbbVie, Anaptys-Bio, Boehringer Ingelheim, Bristol Myers Squibb, Amgen (previously Celgene), Incyte, LEO, Eli Lilly, Menlo, Merck, Novartis, Pfizer, Regeneron, Sun Pharma, Valeant (Ortho Dermatologics), and Vanda.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"JS performed the literature search, data analysis, and initial draft of the work. SMP and BEE critically revised the work.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}}]}}